Adapalene inhibits the activity of cyclin-dependent kinase 2 in colorectal carcinoma

Xinan Shi(Kunming Medical University), Marie C.M. Lin(Shenzhen University)

Molecular Medicine Reports

September 10, 2015

10.3892/mmr.2015.4310

Cited by 63

Related Papers

In Silico Identification and In Vitro and In Vivo Validation of Anti-Psychotic Drug Fluspirilene as a Potential CDK2 Inhibitor and a Candidate Anti-Cancer Drug

|PLoS ONE|2015|85

The antipsychotic agent flupentixol is a new PI3K inhibitor and potential anticancer drug for lung cancer

|International Journal of Biological Sciences|2019|35

Adenosine diphosphate‐ribosylation factor 6 is required for epidermal growth factor‐induced glioblastoma cell proliferation

|Cancer|2009|34

Econazole nitrate inhibits PI3K activity and promotes apoptosis in lung cancer cells

|Scientific Reports|2017|21

Discovery of vanoxerine dihydrochloride as a CDK2/4/6 triple-inhibitor for the treatment of human hepatocellular carcinoma

|Molecular Medicine|2021|12